找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

(版塊PHARMACOLOGY & PHARMACY(藥理學(xué)與藥學(xué))版塊期刊總數(shù):80)
新窗
投票 ESCI期刊Journal of Pharmaceutical Health Care and Sciences 2024/2025影響因子:1.209 (J PHARM HEALTH CARE) (2055-0294). (PHARMA  ...234
Total Citations:400; 2023 JIF:1.209; JIFRank: 290/354 ; Rank-JIF: 290; Number-of-JIF:354; 5 Year JIF:1.412; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.2; Immediacy Index:0.2; Immediacy Index-dealt:0.289; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:48; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.112; Article Influence Score:0.36; JIF Percentile:18.2; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:50; % of Articles in Citable items:0.96; Cited Half-Life:4.7; Citing Half-Life:9.3; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Drugs-Real World Outcomes 2024/2025影響因子:1.937 (DRUGS-REAL WOR OUTC) (2199-1154). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué)  ...234
Total Citations:532; 2023 JIF:1.937; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:1.8; Immediacy Index:0.3; Immediacy Index-dealt:0.351; 2023 JCI:0.58; JCI Rank: 207/354 ; Total Articles:59; JCI Quartile:Q3; JCI Percentile:41.67; Eigenfactor:0.001; Normalized Eigenfactor:0.095; Article Influence Score:0.133; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:NULL; Citable Items:60; % of Articles in Citable items:0.9833; Cited Half-Life:3.1; Citing Half-Life:6.8; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Journal of Psychedelic Studies 2024/2025影響因子:2.211 (J PSYCHEDELIC STUD) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))  ...234
Total Citations:314; 2023 JIF:2.211; JIFRank: 204/354 ; Rank-JIF: 204; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:1.9; Immediacy Index:0.4; Immediacy Index-dealt:0.481; 2023 JCI:0.89; JCI Rank: 103/354 ; Total Articles:22; JCI Quartile:Q2; JCI Percentile:67.21; Eigenfactor:0.001; Normalized Eigenfactor:0.194; Article Influence Score:0.361; JIF Percentile:49.1; JIF Quartile:Q3; AIS Quartile:NULL; Citable Items:28; % of Articles in Citable items:0.7857; Cited Half-Life:3.5; Citing Half-Life:6; % of OA Gold:0.9848; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Journal of Pharmaceutical Policy and Practice 2024/2025影響因子:3.391 (J PHARM POLICY PRACT) (NULL). (PHARMACOLOGY &  ...234
Total Citations:1370; 2023 JIF:3.391; JIFRank: 118/354 ; Rank-JIF: 118; Number-of-JIF:354; 5 Year JIF:3.772; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.6; Immediacy Index-dealt:0.624; 2023 JCI:0.96; JCI Rank: 91/354 ; Total Articles:143; JCI Quartile:Q2; JCI Percentile:74.44; Eigenfactor:0.002; Normalized Eigenfactor:0.442; Article Influence Score:0.835; JIF Percentile:66.8; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:163; % of Articles in Citable items:0.8773; Cited Half-Life:3; Citing Half-Life:6; % of OA Gold:1; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Actualites Pharmaceutiques 2024/2025影響因子:0.124 (ACTUAL PHARMACEUT) (0515-3700). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))  ...234
Total Citations:72; 2023 JIF:0.124; JIFRank: 352/354 ; Rank-JIF: 352; Number-of-JIF:354; 5 Year JIF:0.199; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.086; 2023 JCI:0.03; JCI Rank: 350/354 ; Total Articles:103; JCI Quartile:Q4; JCI Percentile:1.27; Eigenfactor:0; Normalized Eigenfactor:0.01; Article Influence Score:0.009; JIF Percentile:0.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:111; % of Articles in Citable items:0.9279; Cited Half-Life:NULL; Citing Half-Life:6.6; % of OA Gold:0.3524; Publisher name:INT MUSICOLOGICAL SOC; Publisher address:BOX 561, BASEL, SWITZERLAND, CH-4001;
投票 ESCI期刊Journal of Pharmacology & Pharmacotherapeutics 2024/2025影響因子:0.487 (J PHARMACOL PHARMACO) (0976-500X). (PHARMACOL  ...234
Total Citations:1294; 2023 JIF:0.487; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.418; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.3; Immediacy Index-dealt:0.302; 2023 JCI:0.07; JCI Rank: 347/354 ; Total Articles:18; JCI Quartile:Q4; JCI Percentile:2.12; Eigenfactor:0; Normalized Eigenfactor:0.025; Article Influence Score:0.089; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:24; % of Articles in Citable items:0.75; Cited Half-Life:10.7; Citing Half-Life:8.7; % of OA Gold:0.6132; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United Stat
投票 ESCI期刊Therapeutic Delivery 2024/2025影響因子:3.157 (THER DELIV) (2041-5990). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sour  ...234
Total Citations:2566; 2023 JIF:3.157; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.762; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.6; Immediacy Index-dealt:0.686; 2023 JCI:0.7; JCI Rank: 163/354 ; Total Articles:27; JCI Quartile:Q2; JCI Percentile:54.1; Eigenfactor:0.001; Normalized Eigenfactor:0.206; Article Influence Score:0.535; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:53; % of Articles in Citable items:0.5094; Cited Half-Life:7.8; Citing Half-Life:7.5; % of OA Gold:0.094; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBRI
投票 ESCI期刊Journal of Pharmacy & Pharmacognosy Research 2024/2025影響因子:1.249 (J PHARM PHARMACOGN R) (0719-4250). (PHARMACOLOG  ...234
Total Citations:411; 2023 JIF:1.249; JIFRank: 290/354 ; Rank-JIF: 290; Number-of-JIF:354; 5 Year JIF:1.176; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.3; Immediacy Index-dealt:0.346; 2023 JCI:0.41; JCI Rank: 267/354 ; Total Articles:86; JCI Quartile:Q4; JCI Percentile:24.72; Eigenfactor:0; Normalized Eigenfactor:0.07; Article Influence Score:0.128; JIF Percentile:18.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:91; % of Articles in Citable items:0.9451; Cited Half-Life:2.8; Citing Half-Life:6; % of OA Gold:0.4825; Publisher name:IVYSPRING INT PUBL; Publisher address:PO BOX 4546, LAKE HAVEN, AUSTRALIA, NSW, 2263;
投票 ESCI期刊Journal of Pharmacy and Bioallied Sciences 2024/2025影響因子:0.708 (J PHARM BIOALLIED SC) (0976-4879). (PHARMACOLOGY  ...234
Total Citations:3434; 2023 JIF:0.708; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:1.293; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.1; Immediacy Index-dealt:0.107; 2023 JCI:0.2; JCI Rank: 319/354 ; Total Articles:317; JCI Quartile:Q4; JCI Percentile:10.03; Eigenfactor:0.002; Normalized Eigenfactor:0.384; Article Influence Score:0.19; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:350; % of Articles in Citable items:0.9057; Cited Half-Life:8; Citing Half-Life:12.1; % of OA Gold:0.9811; Publisher name:INDERSCIENCE ENTERPRISES LTD; Publisher address:WORLD TRADE CENTER BLDG, 29
投票 ESCI期刊SCIENTIA PHARMACEUTICA 2024/2025影響因子:2.363 (SCI PHARM) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sources  ...234
Total Citations:1840; 2023 JIF:2.363; JIFRank: 199/354 ; Rank-JIF: 199; Number-of-JIF:354; 5 Year JIF:2.921; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.2; Immediacy Index:0.9; Immediacy Index-dealt:0.924; 2023 JCI:0.67; JCI Rank: 171/354 ; Total Articles:41; JCI Quartile:Q2; JCI Percentile:51.84; Eigenfactor:0.001; Normalized Eigenfactor:0.19; Article Influence Score:0.397; JIF Percentile:43.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:55; % of Articles in Citable items:0.7455; Cited Half-Life:6.9; Citing Half-Life:7.7; % of OA Gold:1; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON, E
投票 ESCI期刊JOURNAL OF PHARMACY PRACTICE 2024/2025影響因子:1.113 (J PHARM PRACT) (0897-1900). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Em  ...234
Total Citations:1684; 2023 JIF:1.113; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.266; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.2; Immediacy Index-dealt:0.263; 2023 JCI:0.29; JCI Rank: 293/354 ; Total Articles:64; JCI Quartile:Q4; JCI Percentile:17.37; Eigenfactor:0.002; Normalized Eigenfactor:0.501; Article Influence Score:0.313; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:75; % of Articles in Citable items:0.8533; Cited Half-Life:4.1; Citing Half-Life:6.9; % of OA Gold:0.0444; Publisher name:WORLD SCIENTIFIC PUBL CO PTE LTD; Publisher address:5 TOH TUCK LINK, SINGAPOR
投票 ESCI期刊JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2024/2025影響因子:1.179 (J PHARM PRACT RES) (1445-937X). (PHARMACOLOGY & PH  ...234
Total Citations:546; 2023 JIF:1.179; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:0.9; Immediacy Index:0.1; Immediacy Index-dealt:0.163; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:33; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.501; Article Influence Score:0.313; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:NULL; Citable Items:41; % of Articles in Citable items:0.8049; Cited Half-Life:5.7; Citing Half-Life:6; % of OA Gold:0.2721; Publisher name:INDERSCIENCE ENTERPRISES LTD; Publisher address:WORLD TRADE CENTER BLDG, 29
投票 ESCI期刊JOURNAL OF PHARMACY TECHNOLOGY 2024/2025影響因子:1.192 (J PHARM TECHNOL) (8755-1225). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥  ...234
Total Citations:422; 2023 JIF:1.192; JIFRank: 296/354 ; Rank-JIF: 296; Number-of-JIF:354; 5 Year JIF:1.415; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.1; Immediacy Index:0.1; Immediacy Index-dealt:0.147; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:39; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.118; Article Influence Score:0.355; JIF Percentile:16.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:50; % of Articles in Citable items:0.78; Cited Half-Life:5; Citing Half-Life:6.1; % of OA Gold:0.065; Publisher name:INT MEDICAL RESEARCH & DEVELOPMENT CORP; Publisher address:6308 12TH AVE, NEW YOR
投票 ESCI期刊Reviews on Recent Clinical Trials 2024/2025影響因子:1.468 (REV RECENT CLIN TRIA) (1574-8871). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:592; 2023 JIF:1.468; JIFRank: 275/354 ; Rank-JIF: 275; Number-of-JIF:354; 5 Year JIF:1.552; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.5; Immediacy Index-dealt:0.518; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:23; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.123; Article Influence Score:0.346; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:34; % of Articles in Citable items:0.6765; Cited Half-Life:5.9; Citing Half-Life:6.8; % of OA Gold:0.0244; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS,
投票 ESCI期刊SA Pharmaceutical Journal 2024/2025影響因子:0.284 (SA PHARM J) (2221-5875). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging  ...234
Total Citations:62; 2023 JIF:0.284; JIFRank: 350/354 ; Rank-JIF: 350; Number-of-JIF:354; 5 Year JIF:0.239; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:<0.1; Immediacy Index-dealt:0.083; 2023 JCI:0.01; JCI Rank: 354/354 ; Total Articles:7; JCI Quartile:Q4; JCI Percentile:0.14; Eigenfactor:0; Normalized Eigenfactor:0.009; Article Influence Score:0.039; JIF Percentile:1.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:32; % of Articles in Citable items:0.2188; Cited Half-Life:NULL; Citing Half-Life:7.3; % of OA Gold:0; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LANE, KIDLINGT
投票 ESCI期刊Advances in Pharmacological and Pharmaceutical Sciences 2024/2025影響因子:2.132 (ADV PHARM PHARM SCI) (2633-4682). (P  ...234
Total Citations:331; 2023 JIF:2.132; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.661; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.7; Immediacy Index-dealt:0.787; 2023 JCI:0.62; JCI Rank: 192/354 ; Total Articles:32; JCI Quartile:Q3; JCI Percentile:45.9; Eigenfactor:0; Normalized Eigenfactor:0.078; Article Influence Score:0.372; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:40; % of Articles in Citable items:0.8; Cited Half-Life:2.4; Citing Half-Life:7.4; % of OA Gold:1; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Advances in Pharmacology and Pharmacy 2024/2025影響因子:0.445 (ADV PHARMACOL PHARM) (2332-0036). (PHARMACOLOGY & PHAR  ...234
Total Citations:77; 2023 JIF:0.445; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.515; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.5; Immediacy Index-dealt:0.599; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:27; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.058; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:31; % of Articles in Citable items:0.871; Cited Half-Life:NULL; Citing Half-Life:10.4; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Canadian Pharmacists Journal 2024/2025影響因子:1.626 (CAN PHARM J) (1715-1635). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emer  ...234
Total Citations:801; 2023 JIF:1.626; JIFRank: 259/354 ; Rank-JIF: 259; Number-of-JIF:354; 5 Year JIF:2.128; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.3; Immediacy Index:0.4; Immediacy Index-dealt:0.413; 2023 JCI:0.32; JCI Rank: 290/354 ; Total Articles:30; JCI Quartile:Q4; JCI Percentile:18.22; Eigenfactor:0.001; Normalized Eigenfactor:0.145; Article Influence Score:0.439; JIF Percentile:27; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:32; % of Articles in Citable items:0.9375; Cited Half-Life:6.3; Citing Half-Life:5.9; % of OA Gold:0.5981; Publisher name:BEILSTEIN-INSTITUT; Publisher address:TRAKEHNER STRASSE 7-9, FRANKFURT AM MAIN
投票 ESCI期刊Jundishapur Journal of Natural Pharmaceutical Products 2024/2025影響因子:1.141 (JUNDISHAPUR J NAT PH) (1735-7780). (P  ...234
Total Citations:556; 2023 JIF:1.141; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:0.996; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.1; Immediacy Index-dealt:0.197; 2023 JCI:0.23; JCI Rank: 307/354 ; Total Articles:40; JCI Quartile:Q4; JCI Percentile:13.42; Eigenfactor:0; Normalized Eigenfactor:0.057; Article Influence Score:0.136; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.8889; Cited Half-Life:7; Citing Half-Life:7.7; % of OA Gold:0.9926; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON
投票 ESCI期刊US PHARMACIST 2024/2025影響因子:0.384 (US PHARM) (0148-4818). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sources Citat  ...234
Total Citations:332; 2023 JIF:0.384; JIFRank: 344/354 ; Rank-JIF: 344; Number-of-JIF:354; 5 Year JIF:0.481; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:0.1; Immediacy Index-dealt:0.133; 2023 JCI:0.05; JCI Rank: 349/354 ; Total Articles:90; JCI Quartile:Q4; JCI Percentile:1.55; Eigenfactor:0; Normalized Eigenfactor:0.055; Article Influence Score:0.077; JIF Percentile:3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:91; % of Articles in Citable items:0.989; Cited Half-Life:6.5; Citing Half-Life:6.4; % of OA Gold:0; Publisher name:WEST AFRICAN ORNITHOLOGICAL SOC; Publisher address:C/O DR ALAN TYE, EDITOR, 2 SCHOOL LANE,
下一頁 »
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 06:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
返回頂部 返回版塊
龙川县| 邳州市| 惠安县| 涿州市| 施甸县| 玉溪市| 永川市| 北流市| 绥芬河市| 新余市| 岢岚县| 洮南市| 安泽县| 潞西市| 苍山县| 灵寿县| 松潘县| 舟山市| 贡嘎县| 盱眙县| 溆浦县| 云林县| 华阴市| 金坛市| 杭州市| 铜鼓县| 当阳市| 来宾市| 延川县| 祁连县| 迁安市| 屯门区| 通化县| 天门市| 蒲江县| 潼南县| 龙岩市| 天柱县| 惠水县| 射阳县| 皋兰县|